A breakthrough treatment for rectal cancer may see tumours completely vanish, potentially sparing patients from aggressive surgeries while maintaining vital bodily functions, reports Wales Online.
Researchers at Sweden’s Uppsala University have introduced a new approach that could lead to the disappearance of rectal cancer tumours. With over 40,000 Britons affected by the disease annually, this discovery offers hope for improved outcomes.
The team, led by Professor Bengt Glimelius, revealed that the new treatment regimen could eliminate tumours more frequently, increasing the chances of avoiding surgery and preserving normal rectal function. Compared to the current standard care involving chemotherapy, radiotherapy, bowel removal, and subsequent treatments, this novel method aims to use a more intense initial dose of chemotherapy and radiotherapy, potentially reducing or eliminating the need for surgery altogether.
Professor Glimelius explained that if the tumour completely vanishes during treatment, surgical intervention may not be necessary. This approach could help retain the rectum and eliminate the need for a stoma, thereby improving post-treatment quality of life.
Rectal cancer patients often face challenges post-surgery, including the adjustment to new bodily functions. By focusing on tumour eradication first, the Uppsala researchers aim to enhance patient outcomes and reduce long-term complications associated with current treatment approaches.
This groundbreaking research offers new hope for rectal cancer patients, potentially revolutionizing treatment protocols and improving overall quality of life for those affected by the disease.